Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16362225 | 0.87 | CNR1 (0.69) | CNR1CNR2 | |
| SCHEMBL20394666 | 0.87 | CNR1 (0.95) | CNR1CNR2 | |
| SCHEMBL15094476 | 0.87 | CNR1 (0.91) | CNR1CNR2 | |
| SCHEMBL20394668 | 0.84 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL15094857 | 0.84 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL15099324 | 0.83 | CNR1 (0.90) | CNR1CNR2 | |
| SCHEMBL15094521 | 0.83 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL15094519 | 0.83 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL30571176 | 0.83 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL15099336 | 0.83 | CNR1 (1.00) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2019-08-13 | — | — | US | disclosed |
| US-10246414-B2 | Allosteric modulators of CB1 cannabinoid receptors | NORTHEASTERN UNIVERSITY (US) | 2019-04-02 | — | — | US | disclosed |
| US-10246414-B2 | Allosteric modulators of CB1 cannabinoid receptors | NORTHEASTERN UNIVERSITY (US) | 2019-04-02 | — | — | US | disclosed |
| EP-2800569-B1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | UNIV NORTHEASTERN (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-2800569-B1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | UNIV NORTHEASTERN (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2018-05-03 | — | — | US | disclosed |
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2018-05-03 | — | — | US | disclosed |
| US-20170197918-A1 | Allosteric Modulators of CB1 Cannabinoid Receptors | NORTHEASTERN UNIVERSITY | 2017-07-13 | — | — | US | disclosed |
| US-20170197918-A1 | Allosteric Modulators of CB1 Cannabinoid Receptors | NORTHEASTERN UNIVERSITY | 2017-07-13 | — | — | US | disclosed |
| US-20170197918-A1 | Allosteric Modulators of CB1 Cannabinoid Receptors | NORTHEASTERN UNIVERSITY | 2017-07-13 | — | — | US | disclosed |
| US-9556118-B2 | Allosteric modulators of CB1 cannabinoid receptors | NORTHEASTERN UNIVERSITY (US) | 2017-01-31 | — | — | US | disclosed |
| US-9556118-B2 | Allosteric modulators of CB1 cannabinoid receptors | NORTHEASTERN UNIVERSITY (US) | 2017-01-31 | — | — | US | disclosed |
| US-9556118-B2 | Allosteric modulators of CB1 cannabinoid receptors | NORTHEASTERN UNIVERSITY (US) | 2017-01-31 | — | — | US | disclosed |
| WO-2016029310-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-03-03 | — | — | WO | disclosed |
| US-20150005346-A1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | NORTHEASTERN UNIVERSITY | 2015-01-01 | — | — | US | disclosed |
| US-20150005346-A1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | NORTHEASTERN UNIVERSITY | 2015-01-01 | — | — | US | disclosed |
| US-20150005346-A1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | NORTHEASTERN UNIVERSITY | 2015-01-01 | — | — | US | disclosed |
| WO-2013103967-A1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | NORTHEASTERN UNIVERSITY (US) | 2013-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005346-A1 | ALLOSTERIC MODULATORS OF CB1 CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885 |
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885 |
| US-10246414-B2 | Allosteric modulators of CB1 cannabinoid receptors | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885 |
| US-10377711-B2 | Cannabinoid type 1 receptor modulators | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885 |
| US-20170197918-A1 | Allosteric Modulators of CB1 Cannabinoid Receptors | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.